Virgilagicin
Virgilagicin is a Gram-positive active antibiotic that has a dual polyprenyl phosphate binding mechanism that impedes resistance development[1].
Product Specifications
UNSPSC
12352209
Target
Antibiotic; Bacterial
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/virgilagicin.html
Solubility
10 mM in DMSO
Smiles
N=C(NCCC[C@@H](NC1=O)C(N[C@H](C(NCC(N[C@@H](C(N[C@@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O[C@@H]([C@@H]1NC(CCCCCCCCCCCCC)=O)C)=O)C(C)C)=O)CCCNC(N)=N)=O)C(C)C)=O)CC2=CC=C(O)C=C2)=O)=O)CC(O)=O)=O)CC(N)=O)=O)=O)CC(O)=O)=O)N
Molecular Formula
C65H106N18O19
Molecular Weight
1443.65
References & Citations
[1]Adam F Rosenzweig, et al. A Family of Antibiotics That Evades Resistance by Binding Polyprenyl Phosphates. ACS Infect Dis. 2023 Dec 8;9 (12) :2394-2400.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682866-500 1x 500 µL
HLA-DQ (MHC II) (HLA-DQA1/2866R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
